RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ)
$3.18 -0.11 (-3.3435%)
Analysed RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ) News Sources
Recursion’s AI Drug Pipeline Progress Tests Investor Patience And Valuation
04-06-2026
yahoo.com
Why Recursion Pharmaceuticals (RXRX) Is Up 9.5% After AI Pipeline Progress And Stronger-Than-Expected Q1 Results
04-06-2026
yahoo.com
Recursion (RXRX) Climbs 9.5% Ahead of Next Week’s Business Updates
05-06-2026
yahoo.com
Recursion Pharmaceuticals (RXRX) Up 16.2% Since Last Earnings Report: Can It Continue?
05-06-2026
yahoo.com
Recursion Pharmaceuticals (RXRX) Dips More Than Broader Market: What You Should Know
10-06-2026
yahoo.com
Why Is Allogene Therapeutics (ALLO) Down 12.2% Since Last Earnings Report?
12-06-2026
yahoo.com
Recursion Pharmaceuticals (RXRX) Stock Valuation After AI Drug Discovery And REC-1245 REC-4881 Updates
13-06-2026
yahoo.com
Cathie Wood Buys $444 Million in SpaceX, Dumps Tesla and AMD
15-06-2026
yahoo.com
X-Energy (XE) Powers 13.5% as Cathie Wood Gobbles More Stake
16-06-2026
yahoo.com
Why Recursion Pharmaceuticals (RXRX) Dipped More Than Broader Market Today
16-06-2026
yahoo.com
What is the current price of RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ)?
The current price of RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ) is $3.18.
RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ) since the previous trading day is $-0.11.
RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ) since the previous trading day is -3.3435%.
What is the most recent average sentiment score for RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ)?
The most recent average sentiment score for RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ)?
The most recent sentiment for RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ) is .
SEC-8K** Filing Available For RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.